Aridol Kit — Competitive Intelligence Brief

Aridol Kit (MANNITOL) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic Diuretic [EPC]. Area: Immunology.

marketed Osmotic Diuretic [EPC] sodium channels Immunology Small molecule

Target snapshot

Aridol Kit (MANNITOL) — Baxter. Mannitol works by drawing water into the bloodstream from surrounding tissues, increasing urine production and reducing fluid accumulation in the body.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Aridol Kit TARGET	MANNITOL	Baxter	marketed	Osmotic Diuretic [EPC]	sodium channels	1964-01-01
Cordarone	AMIODARONE	Pfizer	marketed	Antiarrhythmic	sodium channels, potassium channels, calcium channels	1985-01-01
MEXILETINE HYDROCHLORIDE	MEXILETINE HYDROCHLORIDE		marketed		sodium channels	1985-01-01
Norpace Cr	Disopyramide Phosphate	Pfizer	marketed	Type 1 antiarrhythmic	Cardiac sodium channels; cardiac cells with augmented automaticity	1977-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Amide local anesthetic	Nerve sodium channels	1972-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Amide local anesthetic	Nerve sodium channels	1972-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Local anesthetic	Sodium channels	1972-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic Diuretic [EPC] class)

1. Baxter · 1 drug in this class